Family Practice NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024DermatologyRheumatologyGastroenterologyMusculoskeletal Disorders
Family Practice NewsNew Cause of Sexually Transmitted Fungal Infection Reported in MSMNovember 13, 2024Infectious DiseasesDermatology
Family Practice NewsDuloxetine Bottles Recalled by FDA Because of Potential CarcinogenOctober 28, 2024PainDiabetesMental Health
Family Practice NewsTirzepatide Shortage Resolved? FDA Says Yes, Compounders NoOctober 7, 2024ObesityEndocrinology
Family Practice NewsFDA OKs Next-Gen Cologuard Test for CRC ScreeningOctober 4, 2024Colorectal CancerGastroenterologyOncology
Family Practice NewsFDA Approves Ustekinumab Biosimilar OtulfiOctober 3, 2024GastroenterologyPediatricsImmunologyRheumatology
Family Practice NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024DermatologyRheumatology
Family Practice NewsFDA OKs Adjuvant Ribociclib in Earlier Stage Breast CancerSeptember 23, 2024OncologyWomen's Health
Family Practice NewsBenralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Rare DiseasesRheumatologyNephrologyPulmonologyAsthma
Family Practice NewsFDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer IndicationsSeptember 17, 2024Mixed TopicsPractice ManagementOncologyHepatologyDermatologyPulmonology
Family Practice NewsFDA Grants Livdelzi Accelerated Approval for Primary Biliary CholangitisAugust 14, 2024HepatologyGastroenterology
Family Practice NewsFDA Expands Dostarlimab-gxly Approval for Endometrial CancerAugust 2, 2024OncologyWomen's Health
Family Practice NewsCompounded Semaglutide Overdoses Tied to HospitalizationsJuly 30, 2024ObesityDiabetes
Family Practice NewsBreakthrough Blood Test for Colorectal Cancer Gets Green LightJuly 30, 2024GastroenterologyPreventive CareOncology
Family Practice NewsFDA OKs Voquezna for Heartburn Relief in Nonerosive Gastroesophageal Reflux DiseaseJuly 19, 2024GastroenterologyHeartburn/Acid Reflux
